Andrew A Perez

CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops

Dennis J. Hazelett, G. Coetzee, P. Farnham, 2018, Genome Biology.

ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream from transcription start sites at the majority of CpG island promoters

P. Farnham, Heather Witt, S. Rhie, 2018, Genome research.

dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression

P. Farnham, J. Mackay, D. Segal, 2017, Nucleic acids research.

Characterization of the ZFX family of transcription factors that bind downstream of the start site of CpG island promoters

P. Farnham, C. Nicolet, S. Schreiner, 2020, Nucleic acids research.

A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome

P. Farnham, F. Lay, S. Rhie, 2019, Nature Communications.

CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops

G. Coetzee, P. Farnham, S. Rhie, 2018, Genome Biology.